Article Text

PDF

0440 A systemic review and meta-analysis of exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function
  1. Se Yeong Kim1,
  2. Shin Ae KIM1,
  3. Chunhui Suh1,
  4. Kun Hyung Kim1,
  5. Chae Kwan Lee1,
  6. Byung Chul Son1,
  7. Jeong Ho Kim1,
  8. Jong Tae Lee1,
  9. Jung IL Kim2
  1. 1Department of Occupational and Environmental Medicine and Institute of Environmental and Occupational Medicine, Busan Paik Hospital, Inje University, Busan/Busanjin-Gu, Republic of Korea
  2. 2Department of Occupational and Environmental Medicine and Institute of Environmental and Occupational Medicine, Busan Paik Hospital, Dong-a University, Busan/Seo-Gu, Republic of Korea

Abstract

Objectives Fractional exhaled nitric oxide (FeNO) has been implicated as a pulmonary biomarker in various respiratory disease, including COPD. Measurement of FeNO is a simple, non-invasive tool for assessing airway inflammation. Neverthless, the usefulness of FeNO measurements in COPD patient in clinical practice is unclear. The objective of this review was to evaluate the efficacy of management of COPD based on FeNO in comparison with pulmonary function test.

Method Cochrane library (CENTRAL), MEDLINE, EMBASE and reference lists of articles were searched. The last searches were in July 2013. Results of searches were reviewed against predominantly criteria for inclusion. Relevant studies were selected, assessed and data extracted independently by two people. Participant articles with COPD management based on pulmonary function test compared with FeNO measurement were selected. Risk of bias for each study was assessed using the QUADAS(quality assessment of studies of diagnosis accuracy included in systematic reviews) scale.

Results Finally, eight studies were included. Of the eight studies, four were a negative and one were positive correlation between FeNO and pulmonary functions. Three studies were not significant correlation. The various results of studies were effected by characteristics of the patients (COPD severity, smoking status, treatment status) and differences in FeNO measurement methods.

Conclusions The studies includes in this review highlight the difficulties of correlation between FeNO and pulmonary function. So, the role of add-on monitoring of FeNO to pulmonary function test is less clear because of the absence of conclusive double-blind, randomised, control studies concerning potential clinical benefits in the management of COPD. Further randomised controlled trials are required.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.